Bromide

Bromide

SCHEMBL14976366

Br.CCC(c1ccccc1)C(N)(c1ccccc1)c1ccccc1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41
NOS3 P29474 1/20 0.40
NOS2 P35228 1/20 0.40
KCNN4 O15554 2/20 0.38
TAAR1 Q96RJ0 5/20 0.36
AOC3 Q16853 1/20 0.36
HTR2A P28223 1/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2D6 P10635 1/20 0.35
MIF P14174 1/20 0.34
KIF11 P52732 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
TSHR P16473 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2679440 0.98 LMNA (0.42) LMNANOS3NOS2KCNN4TAAR1
Water SCHEMBL11129302 0.96 LMNA (0.41) LMNANOS3NOS2KCNN4TAAR1
SCHEMBL4592902 0.82 LMNA (0.42) LMNANOS3NOS2KCNN4TAAR1
Bromide SCHEMBL5085160 0.80 HTR2A (0.41) HTR2A
Bromide SCHEMBL5087833 0.80 HTR2A (0.41) HTR2A
SCHEMBL11575081 0.79 LMNA (0.44) LMNANOS3NOS2KCNN4AOC3
Bromide SCHEMBL6520617 0.78 LMNA (0.42) LMNANOS3NOS2TAAR1AOC3
SCHEMBL27433852 0.78 KCNN4 (0.39) KCNN4TAAR1HTR2A
SCHEMBL7564248 0.78 LMNA (0.45) LMNANOS3NOS2TAAR1AOC3
SCHEMBL756292 0.78 LMNA (0.45) LMNANOS3NOS2KCNN4TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113999492-A UV-resistant aging-resistant high-performance LED epoxy resin composition and preparation method thereof 无锡嘉联电子材料有限公司 2022-02-01 CN claimed
CN-113999492-A UV-resistant aging-resistant high-performance LED epoxy resin composition and preparation method thereof 无锡嘉联电子材料有限公司 2022-02-01 CN disclosed
US-9593071-B2 Process for the preparation of gamma amino acids and intermediates used in said process ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) 2017-03-14 US disclosed
US-20140336412-A1 PROCESS FOR THE PREPARATION OF GAMMA AMINO ACIDS AND INTERMEDIATES USED IN SAID PROCESS ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) 2014-11-13 US disclosed
EP-2782911-A1 PROCESS FOR THE PREPARATION OF GAMMA AMINO ACIDS AND INTERMEDIATES USED IN SAID PROCESS Royal College of Surgeons in Ireland (IE) 2014-10-01 EP disclosed
WO-2013076225-A1 PROCESS FOR THE PREPARATION OF GAMMA AMINO ACIDS AND INTERMEDIATES USED IN SAID PROCESS ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) 2013-05-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140336412-A1 PROCESS FOR THE PREPARATION OF GAMMA AMINO ACIDS AND INTERMEDIATES USED IN SAID PROCESS GLRB, GABRP, GABRG1 LMNA 1563/4885NOS3 2678/4885NOS2 2507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.